Pill Imprint TEVA 8229 TEVA 8229
This yellow capsule-shape pill with imprint TEVA 8229 TEVA 8229 on it has been identified as: Sunitinib 37.5 mg.
This medicine is known as sunitinib. It is available as a prescription only medicine and is commonly used for Gastrointestinal Stromal Tumor, Pancreatic Cancer, Renal Cell Carcinoma.
Details for pill imprint TEVA 8229 TEVA 8229
- Drug
- Sunitinib
- Imprint
- TEVA 8229 TEVA 8229
- Strength
- 37.5 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Size
- 16mm
- Availability
- Prescription only
Pill Classification
- National Drug Code (NDC)
- 000938229 - Teva Pharmaceuticals USA, Inc.
Read this next
-
Your Kidney Cancer Treatment Options
If you've been diagnosed with kidney cancer your treatment options will depend largely on the stage at which your cancer was diagnosed
-
Kidney Cancer Stages Explained
Kidney cancer from stage 1 to 4 - what the numbers mean
-
Stage 4 Kidney Cancer: Understanding the Prognosis
Your prognosis following a stage 4 kidney cancer diagnosis can vary greatly depending on how far your disease has spread from the kidney
